• +886-3-5797779

最新新聞

  • 新冠肺炎快篩試劑相關認證
Dec. 24. 2020-
VSTRIP COVID-19 ANTIGEN RAPID TEST ACQUIRED PROVISIONAL AUTHORIZATION FROM SINGAPORE HEALTH SCIENCES AUTHORITY (HSA)

Vstrip COVID-19 Antigen Rapid Test acquired provisional authorization from Singapore Health Sciences Authority (HSA).
Antaimmu.com AnTaimmu BioMed 安肽生醫
Dec. 02. 2020-
VSTRIP COVID-19 ANTIGEN RAPID TEST OBTAINS CE MARKING

PANION & BF BIOTECH INC. XIZHI FACTORY is notified by Obelis s.a. on 2020/12/01 that Vstrip COVID-19 Antigen Rapid Test is in compliance with European Council Directive 98/97/EC – article 10 requirements.
Antaimmu.com AnTaimmu BioMed 安肽生醫
Sep .25. 2020-
VSTRIP COVID-19 ANTIGEN RAPID TEST IS VALIDATED AND FOUND TO BE SATISFACTORY BY INDIA COUNCIL OF MEDICAL RESEARCH (ICMR).

Vstrip COVID-19 Antigen Rapid Test is validated and found to be satisfactory by India Council of Medical Research (ICMR).
Antaimmu.com AnTaimmu BioMed 安肽生醫
Aug .27. 2020-
VSTRIP COVID-19 ANTIGEN RAPID TEST ACQUIRED APPROVAL FROM TAIWAN MINISTRY OF HEALTH AND WELFARE

Vstrip COVID-19 Antigen Rapid Test is approved by Taiwan Ministry of Health and Welfare in response to emergency public health circumstances.
Approval Number: Case-Specific Approval of Disease Control for Manufacture No. 1096813815
>Antaimmu.com AnTaimmu BioMed 安肽生醫

活動訊息

zh_TWZH_TW